Abstract: Pharmaceutical compositions are disclosed that are of use for the treatment of uveitis. These compositions include a suppressive oligonucleotide. These compositions including an immunosuppressive oligonucleotide can be used for the treatment of uveitis, including anterior, posterior, and diffuse uveitis.
Type:
Application
Filed:
May 5, 2005
Publication date:
March 26, 2009
Applicant:
THE GOVERNMENT OF THE U.S. OF AMERICA AS REPRESENTED BY THE SECRETARY OF DEPT OF HEALTH
Inventors:
Dennis M. Klinman, Igal Gery, Chiaki Fujimoto
Abstract: The present disclosure relates to the decontamination of articles or areas contaminated with one or more pathogens. Methods and apparatuses are disclosed that can be used to decontaminate an environment, for example a room, building, or articles contaminated with a pathogen.
Type:
Application
Filed:
October 18, 2005
Publication date:
November 20, 2008
Applicants:
GOVERNMENT OF THE U.S.A. OF AMERICA AS REPRESENTED, CDG RESEARCH CORPORATION, CDIC, INC.
Inventors:
Deborah E. Wilson, Murray L. Cohen, Thomas McWhorter
Abstract: This invention pertains to the discovery of a novel family of thiolesters and uses thereof. Also provided for are viricidal compounds and pharmaceutical formulations comprising these novel thiolesters. The invention also provides thiolester-inactivated viruses and thiolester-complexed viral proteins.
Type:
Application
Filed:
December 16, 2003
Publication date:
July 8, 2004
Applicant:
The Government of the U. S.of America as Represented by The Sec. of Health and Human Svc.
Inventors:
James A. Turpin, Yongsheng Song, Ettore Appella, John K. Inman, David G. Covell, William G. Rice, Anders Wallqvist, Andrew Maynard, Mingjun Huang